Syngene International Ltd (CMP: Rs 575, Market Cap: Rs 23,018 crore), a leading contract research organisation (CRO), reported another steady set of results in the quarter gone by. While the management guided FY22 top line growth in the mid-teens, net profit growth is expected to be mediocre as the company continues to invest heavily in manpower and R&D facilities. Investors should factor in these investments as necessary ones for the development of skills and research required in the long term. It...
Moneycontrol Pro Panorama | Catch-22 for markets
May 17, 2022 / 03:21 PM IST
In today’s edition of Moneycontrol Pro Panorama: A quality bet, PPL’s tryst with market, what Adani buy means, Guruspeak and more
Read NowMoneycontrol Pro Weekender | Losing faith
May 7, 2022 / 10:05 AM IST
Central banks have a trust problem with financial markets over their ability to steer economies towards a soft landing
Read NowTo read the full story, Subscribe to Moneycontrol PRO
Access the exclusive stories, weekly investment ideas and daily technical calls in an Ad free experience
Already a member? Sign in
Limited Period offer on Moneycontrol PRO. Subscribe to PRO and get up to
Ad free experience
Experience a non-intrusive navigation and faster response in the ad free mode
Sharpest Opinions
Access to 230+ exclusive stories per month from our editorial and Experts
+
Have a Global edge with access to content from world renowned experts and journalist
Actionable Insights
Access to 40+ weekly investment ideas including 4 daily technical calls
Virtual Events
Exclusive access to live webinars from market experts on trading and investment strategies
Newsletters
Daily and weekly insights bundled and sent to your inbox to keep you ahead in the race.
Get upto 50% discount on limited period offers